Paratek Pharmaceuticals to Present at the 2019 H.C Wainwright Global Life Sciences Conference

NEXT STORY
Corbus Pharmaceuticals Provides Management Team Updates
PREV STORY
Inovalon Data Powers New Insights on Diverse Healthcare Populations
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial

author_avatar
NASDAQ Market News

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

author_avatar
NASDAQ Market News

Novartis delivers solid Q3 performance with 11% core operating income growth, net sales in line with prior year, strong pipeline progression. Upgrades full year core operating income guidance.

author_avatar
NASDAQ Market News